Neurology® Podcast

Pharmacy Benefits and Disease-Modifying Therapies

Informações:

Synopsis

Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.